Hurtado, Maria Daniela

Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity

Ghusn, W., De la Rosa, A., Sacoto, D., Cifuentes, L., Campos, A., Feris, F., Hurtado, M. D., & Acosta, A. (2022) · JAMA Network Open

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 238

Glucagon-like receptor-1 agonists for obesity: weight loss outcomes, tolerability, side effects, and risks

Ghusn, W., & Hurtado, M. D. (2024) · Obesity Pillars

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 122

Extensive clinical experience: hypothalamic-pituitary-adrenal axis recovery after adrenalectomy for corticotropin-independent cortisol excess

Hurtado, M. D., Cortes, T., Natt, N., Young, W. F., & Bancos, I. (2018) · Clinical Endocrinology

Adrenal Hormones and DisordersPituitary Gland Disorders and Treatments

Cited by 76

Low Incidence of Pulmonary Aspiration During Upper Endoscopy in Patients Prescribed a Glucagon-Like Peptide 1 Receptor Agonist

Anazco, D., Fansa, S., Hurtado, M. D., Camilleri, M., & Acosta, A. (2024) · Clinical Gastroenterology and Hepatology

Diabetes Treatment and ManagementGastrointestinal Bleeding Diagnosis and Treatment

Cited by 58

Weight loss and cardiovascular disease risk outcomes of semaglutide: a one-year multicentered study

Ghusn, W., Fansa, S., Anazco, D., Tama, E., Nicolalde, B., Gala, K., De la Rosa, A., Sacoto, D., Cifuentes, L., Campos, A., et al. (2024) · International Journal of Obesity

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 35